UNSPSC 85533023: Restriction of right renal vein with intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of right renal vein with intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06V93DZ

UNSPSC 85533023, Restriction of right renal vein with intraluminal device, percutaneous approach, is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The six opportunities posted since July 2026 span independent medical evaluation services for pension boards, surgical benefit carve-out programs, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing—none of which involve vascular interventional procedures or renal vein restriction devices. The code's abstract clinical description bears no relationship to the work actually being solicited by state and local buyers, suggesting a tagging or classification error rather than genuine demand for the named procedure.

State and local issuing bodies posting under this code include county human resources departments, county health systems, county probation offices, city retirement boards, and state transportation agencies. The geographic spread includes Arizona (Phoenix), California (Long Beach and Santa Clara County), Texas (Harris County), Florida (Collier County), and Washington (statewide WSDOT). Representative recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services due October 16, 2026 at $750,000 over five years, the Washington State Department of Transportation RFP for occupational medical surveillance services due October 9, 2026 with a two-year initial term, and Collier County's RFP for pharmacy benefit management services originally due April 9, 2026 covering approximately $8.7 million in annual historical spend. The code shows no relevant recent activity for the vascular intervention procedure it nominally describes.